Cancer Metabolism Based Therapeutics Are Becoming Increasingly Popular Due To Minimal Side Effects And Better Results

 Cancer Metabolism Based Therapeutics identifies seven key players in the field of cancer metabolism. These include GHR, GDF, GRD, KIT, insulin, ATP, and ribose. The first three are biological molecules that are essential to life. GRD is a protein known as the glycoside chain of life. GHR and KIT are essential hormones that are required for cell survival and maintenance; GRD is a glycoside of life, known as glycogen. Metabolism Based Therapeutic modalities are becoming increasingly common with the increase in the use of complementary and alternative medicines (CAM) for cancer, HIV, chronic fatigue syndrome, depression, arthritis, pancreatic disorders, head injuries, rheumatoid arthritis, etc. Many patients find these highly effective.

These types of therapies are usually referred to as metabolic therapies. Therapies that use aerobic exercise to enhance the metabolism have shown to improve the ability of the immune system to fight disease and illness and they can be quite beneficial in combating the progression of cancer. The ability of the immune system to flush stored toxins and chemicals from the body's tissues and organs has become very important in preventing and fighting disease processes including cancer. Researchers have identified specific foods that speed up metabolism and alter their normal function. Fruits and vegetables contain "good cholesterol" which regulates cholesterol levels. They also are a great source of fiber and the two together make for a healthy diet. Green tea has also been identified as a powerful antioxidant that enhances energy metabolism and may work as an anti-cancer agent.

Cancer metabolism based therapeutics to encourage a healthy lifestyle and an active approach to diet and exercise. To get the most from any therapy, it is important to choose a program that is well designed and follows an easy-to-follow plan. Recently, in June 2021, Ludwig Cancer at Harvard demonstrated how a drug screening method called dynamic BH3 profiling can be used to quickly identify potentially effective combinations of existing drugs for personalized cancer therapy.